Rivastigmine in Chinese patients with subcortical vascular dementia
Vincent Mok1, Adrian Wong1, Simon Ho2, Thomas Leung1, Wynnie WM Lam2, Ka Sing Wong11Department of Medicine and Therapeutics; 2Department of Radiology and Organ Imaging, The Chinese University of Hong Kong, Shatin, Hong Kong, ChinaBackground: We explored the efficacy and tolerability of rivastigmine...
Guardado en:
Autores principales: | Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2718048a3bb43938d742d2def7a6f37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Jennifer L Reingold, et al.
Publicado: (2007) -
Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
por: Ozkan S, et al.
Publicado: (2013) -
Imaging Markers of Subcortical Vascular Dementia in Patients With Multiple-Lobar Cerebral Microbleeds
por: Chia-Yen Lin, et al.
Publicado: (2021) -
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah N, et al.
Publicado: (2017) -
Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)